Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Observational Study to Compare the Short, Mid- and Long-term Prognosis and Outcomes of SRAS-CoV-2 Infected Hospitalized Patients With Cardiovascular Disease (CVD) to SARS-CoV-2 Infected Hospitalized Patients Without CVD: The Geneva Covid-19 CVD Study

NCT04384029 is registered in ClinicalTrials.gov with François MACH as lead sponsor.

NCT NCT04384029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04384029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Observational Study to Compare the Short, Mid- and Long-term Prognosis and Outcomes of SRAS-CoV-2 Infected Hospitalized Patients With Cardiovascular Disease (CVD) to SARS-CoV-2 Infected Hospitalized Patients Without CVD: The Geneva Covid-19 CVD Study
Lead sponsor
François MACH
Phase
Observational
Overall status
Completed
Start date
March 24, 2020
Completion date
July 31, 2021
Enrollment
1,927 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid, cvd